A23. ILD PROGNOSIS AND BIOMARKERS I

14-3-3γ Protein: A Novel Serum Biomarker for Predicting Prognosis in Idiopathic Pulmonary Fibrosis

Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1090 H. Hozumi, T. Isayama, J. Okada, K. Sugiura, H. Yasui, Yuko Suzuki, M. Kono, M. Karayama, K. Furuhashi, N. Enomoto, T. Fujisawa, N. Inui, Y. Nakamura, H. Hayakawa, T. Suda

Outcomes in Patients with IPF Treated with Antifibrotic Therapies Compared with Untreated Patients in the U.S. Medicare Population

Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1104 J. Mooney, S. Reddy, E. Chang, M. Broder, S. Gokhale, M. Corral